Introduction to Equashield
Compounding chemotherapy without proper PPE/Engineering Controls has been linked to both acute and long-term health risks, including cancer.
Short bursts of exposure to hazardous drugs over a long period of time may pose a long term health risk. EQUASHIELD’s easy to use CSTD protects you and your staff from hazardous drug leaks, sprays or aerosols that can be created during drug preparation, administration and disposal.
EQUASHIELD’s easy to use vial adaptors make accessing the vial a breeze, without a need of any assembly fixture.
EQUASHIELD’s Syringe Unit with prefilled sterile air prevents environmental contamination from entering the drug vial, protecting our companion animals. Intuitively designed connectors, make the system extremely simple to use under any conditions.
If you are already using a Closed System today or are thinking about incorporating a Closed System in your Veterinary practice, consider EQUASHIELD CSTD as it is Safe, Simple and Closed.
CLINICALLY PROVEN, ELIMINATES SURFACE CONTAMINATION
“Use of Equashield CSTD eliminates surface contamination with antineoplastic agents” Cleveland Clinic Cancer Center, OH Bernadette A Clark and Paul JM Sessink
“Syringe plunger contamination by hazardous drugs: A comparative study” Barbara Ann Karmanos Cancer Center, Detroit, MI, Stephen T Smith and Mark C Szlaczky
“Treatment time, ease of use and cost associated with use of Equashield, PhaSeal, or no CSTD for administration of cancer chemotherapy to a dog model” Multisite study: College of Veterinary Medicine University of Georgia and 11 Clinics and Hospitals. K. Kicenuik, N. Northrup et al.
“Connector integrity testing to assess the efficacy of multiple closed system transfer devices” Eshelman School of Pharmacy, University of North Carolina
Shawn O. Streeter, Charlotte M. Forshay, Stephanie A. Salch, Stephen F. Eckel
“Evaluation of syringes used for compounding hazardous drugs and the contamination risks to healthcare personnel”
Study Presented at the ASHP Midyear 2014 Residents Poster Session
CUT THE TIME TO COMPOUND IN HALF, TIME SAVED IS MONEY EARNED
“Assessing the efficiency of CSTDs for compounding”
Fouzia Berdi, Pharm.D., Michael F Powell, MS. FASHP et al.
“CLOSED-SYSTEM DRUG TRANSFER DEVICES: COMPARATIVE STUDY OF DIFFERENT MODELS” MASSON F., HENRY C., LANHER P., NOIREZ V., RONDELOT G.; SERVICE DE PHARMACIE – CENTRE HOSPITALIER RÉGIONAL METZ-THIONVILLE – HÔPITAL DE MERCY – ARS-LAQUENEXY
“Comparative Study of Syringe Contamination by Hazardous Drugs” Institute of Energy and Environmental Technology, Duisburg, Germany DR. THEKLA KIFFMEYER, DR. BerTRAND Favier
PREVENTS MICROBIAL INGRESS UP TO 7 DAYS*
“A 7 Days Microbial Ingress Test of Single Use Vials Utilizing the EQUASHIELD CSTD” Study by Nelson Laboratories, Salt Lake City, UT
“Application of vapor containment protocol for CSTD to assess efficacy
during pharmacy compounding and administration of HD” Eshelman School of Pharmacy, University of North Carolina
Charlotte M. Forshay, Shawn O. Streeter, Stephanie A. Salch, Stephen F. Eckel
“Evaluation of Equashield CSTD Compatibility in Prevention of Environmental Contamination, Alcohol vapors detection” Milouda & Migal Laboratories, K.SHMONA, ISRAEL
“Contamination of syringe plungers during the sampling of cyclophosphamide solutions” Le´on Be´rard Cancer Center, Lyon, France Bertrand Favier, Laurence Gilles et al.